James Andrew Huntington
Director/Miembro de la Junta en SDS Therapeutics Ltd. .
Cargos activos de James Andrew Huntington
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
SDS Therapeutics Ltd.
 SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services SDS Therapeutics Ltd. is a British biotechnology company founded in 2020 that provides research and development services. The company is based in Cambridge, UK. | Director/Miembro de la Junta | 18/12/2020 | - |
Historial de carrera de James Andrew Huntington
Antiguos cargos conocidos de James Andrew Huntington.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Z Factor Ltd.
 Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Director/Miembro de la Junta | 01/01/2015 | 29/01/2021 |
| Fundador | 01/01/2015 | 29/01/2021 | |
SuperX Ltd.
 SuperX Ltd. BiotechnologyHealth Technology SuperX Ltd. operates as a biopharmaceutical firm. It develops antibodies with anticoagulant properties. The company was founded by Trevor Baglin, David Grainger, and Jim Huntington and is headquartered in Cambridge, the United Kingdom. | Director/Miembro de la Junta | 10/11/2015 | - |
| Fundador | 10/11/2015 | - | |
ApcinteX Ltd.
 ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | Fundador | 16/06/2014 | - |
Estadísticas
Internacional
| Reino Unido | 5 |
Operativa
| Founder | 3 |
| Director/Board Member | 3 |
Sectorial
| Health Technology | 4 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
ApcinteX Ltd.
ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | Health Technology |
SuperX Ltd.
SuperX Ltd. BiotechnologyHealth Technology SuperX Ltd. operates as a biopharmaceutical firm. It develops antibodies with anticoagulant properties. The company was founded by Trevor Baglin, David Grainger, and Jim Huntington and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Z Factor Ltd.
Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Health Technology |
SDS Therapeutics Ltd.
SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services SDS Therapeutics Ltd. is a British biotechnology company founded in 2020 that provides research and development services. The company is based in Cambridge, UK. | Commercial Services |
